JW Pharma ApS: Financial statements 2022
CVR: 39330563
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
JW Pharma ApS (CVR 39330563) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -7,568 and a net result of DKK -9,158 compared with DKK -35,065 the year before. Equity in the 2022 report amounted to DKK -136,606.
- Gross Profit
- DKK -7,568
- Profit/Loss
- DKK -9,158
- Equity
- DKK -136,606
- Total Assets
- DKK 302,663
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -8 t. | -9 t. | -137 t. | - |
| 2021 | - | -33 t. | -35 t. | -127 t. | - |
| 2020 | - | 70 t. | 69 t. | -92 t. | - |
| 2019 | - | -125 t. | -125 t. | -162 t. | - |
| 2018 | - | -85 t. | -87 t. | -37 t. | - |
Official annual report
Keep an eye on JW Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
JW Pharma ApS has published its annual report for 2021. Gross profit came to DKK -33,146, and the net result was DKK -35,065.
About JW Pharma ApS
JW Pharma ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company has been dissolved on 27 October 2025. The company was registered under the industry Detailhandel med andre fødevarer. In 2024, the company reported a gross profit of DKK -5,857 and a net result of DKK -5,857 compared with DKK -4,637 the year before. Equity in the 2024 report amounted to DKK -147,099.